Gendoo

MeSH keywords -> Related genes, diseases (OMIM)


Query MeSH keywords list

01 Clinical Trials as Topic [NCBI]

Gene


 Gene Link Information
Gain		 01



OMIM


 OMIM Link Information
gain		 01
RA [NCBI] 0.00414946
EGFR [NCBI] 0.00134281
undritz anomaly [NCBI] 0.00132272
VRNI [NCBI] 0.00115585
thyroid hormonogenesis, genetic defect in, 4 [NCBI] 0.000957753
cholesterol level quantitative trait locus 1 [NCBI] 0.000892923
VEGF [NCBI] 0.000352169
KLK3 [NCBI] 0.000343282
CRC [NCBI] 0.000303987
CF [NCBI] 0.000184918
FRAP1 [NCBI] 0.000175744
MDD [NCBI] 0.000167797
SCIDX1 [NCBI] 0.000155825
AD [NCBI] 0.000143136
CJD [NCBI] 0.000100832
GNRH1 [NCBI] 9.95592e-05
car factor deficiency [NCBI] 9.24192e-05
anosmia for isobutyric acid [NCBI] 9.24192e-05
smell ketone compounds, ability to [NCBI] 9.24192e-05
MG [NCBI] 7.59446e-05
KDR [NCBI] 7.49174e-05
TYMS [NCBI] 7.34896e-05
PWS [NCBI] 7.1602e-05
HAE [NCBI] 6.85855e-05
RP [NCBI] 6.82072e-05
IFNA1 [NCBI] 6.62011e-05
GIST [NCBI] 5.56404e-05
isovaleric acid, inability to smell [NCBI] 5.45615e-05
NSIAD [NCBI] 5.45615e-05
glutamate monosodium sensitivity [NCBI] 5.45615e-05
SLE [NCBI] 5.43157e-05
IFNA2 [NCBI] 4.79857e-05
PTH [NCBI] 4.70646e-05
TNF [NCBI] 4.51352e-05
alopecia, androgenetic [NCBI] 4.18966e-05
ACPP [NCBI] 3.93338e-05
NPY [NCBI] 3.91619e-05
COMT [NCBI] 3.42398e-05
ADA [NCBI] 3.33962e-05
CEACAM5 [NCBI] 3.12817e-05
FA [NCBI] 3.11562e-05
fabry disease [NCBI] 3.11559e-05
osteogenic sarcoma [NCBI] 3.11179e-05
aspirin resistance [NCBI] 3.11179e-05
EPO [NCBI] 3.10053e-05
MPO [NCBI] 2.87006e-05
osteoporosis, juvenile [NCBI] 2.56556e-05
VIP [NCBI] 2.47426e-05
TNFSF10 [NCBI] 2.41072e-05
thrombocytopenic purpura, autoimmune [NCBI] 2.40925e-05
hurler syndrome [NCBI] 2.38572e-05
SST [NCBI] 2.3123e-05
JLNS1 [NCBI] 2.28408e-05
vitamin d-dependent rickets, type i [NCBI] 2.16082e-05
PPARA [NCBI] 2.13888e-05
AS [NCBI] 2.09542e-05
FTD [NCBI] 2.08911e-05
EGF [NCBI] 2.02746e-05
dopamine beta-hydroxylase deficiency, congenital [NCBI] 1.9418e-05
lymphoma, non-hodgkin, familial [NCBI] 1.86742e-05
hyperimmunoglobulin e recurrent infection syndrome, autosomal dominant [NCBI] 1.84385e-05
CHAT [NCBI] 1.80211e-05
SLC46A1 [NCBI] 1.79849e-05
ACHE [NCBI] 1.79731e-05
AT [NCBI] 1.79631e-05
BGLAP [NCBI] 1.73344e-05
XPNPEP2 [NCBI] 1.70084e-05
stroke, ischemic [NCBI] 1.66693e-05
polycythemia vera [NCBI] 1.66693e-05
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-positive [NCBI] 1.66693e-05
PARP4 [NCBI] 1.61753e-05
CASR [NCBI] 1.60926e-05
EBR1 [NCBI] 1.58669e-05
ETM1 [NCBI] 1.58669e-05
TFPI [NCBI] 1.58479e-05
protein c deficiency, congenital thrombotic disease due to [NCBI] 1.52555e-05
THPO [NCBI] 1.5104e-05
IRF4 [NCBI] 1.42305e-05
FGF7 [NCBI] 1.37214e-05
thrombasthenia of glanzmann and naegeli [NCBI] 1.36786e-05
LPL [NCBI] 1.33604e-05
diabetes insipidus, nephrogenic, x-linked [NCBI] 1.24921e-05
LMO2 [NCBI] 1.23881e-05
DHFR [NCBI] 1.22532e-05
PRL [NCBI] 1.22354e-05
KEAP1 [NCBI] 1.16586e-05
FPGS [NCBI] 1.15511e-05
HGF [NCBI] 1.11107e-05
ACTA1 [NCBI] 1.10172e-05
testicular tumors [NCBI] 1.08626e-05
amyloidosis vi [NCBI] 1.07698e-05
NPPA [NCBI] 1.00653e-05
TLR9 [NCBI] 9.67613e-06
IL12A [NCBI] 9.46407e-06
CML [NCBI] 8.62251e-06
PF4 [NCBI] 7.96739e-06
CLN3 [NCBI] 7.86015e-06
F3 [NCBI] 7.81992e-06
MAOB [NCBI] 7.7801e-06
HLA-B [NCBI] 7.7801e-06
GRPR [NCBI] 7.62483e-06
NGFB [NCBI] 7.57136e-06
CRH [NCBI] 7.28555e-06
CTNS [NCBI] 7.16151e-06
ASPA [NCBI] 7.05109e-06
APOE [NCBI] 6.93813e-06
ABO [NCBI] 6.91826e-06
protoporphyria, erythropoietic [NCBI] 6.54194e-06
LKS [NCBI] 6.51995e-06
FOP [NCBI] 6.51995e-06
tyrosinemia, type i [NCBI] 6.08573e-06
DNMT1 [NCBI] 6.08135e-06
ALAD [NCBI] 5.77297e-06
FGF23 [NCBI] 5.67371e-06
XPA [NCBI] 5.65254e-06
isoniazid inactivation [NCBI] 5.4821e-06
SPP1 [NCBI] 5.4063e-06
APOB [NCBI] 5.37984e-06
AR [NCBI] 5.25001e-06
ABL1 [NCBI] 5.2107e-06
KIT [NCBI] 5.12419e-06
temporal arteritis [NCBI] 4.59041e-06
GAPDH [NCBI] 4.38485e-06
BDNF [NCBI] 4.34383e-06
AFP [NCBI] 4.32291e-06
PGR [NCBI] 4.27878e-06
HHT [NCBI] 4.20528e-06
ABCD1 [NCBI] 4.01942e-06
TLR3 [NCBI] 3.95653e-06
TF [NCBI] 3.91248e-06
F2R [NCBI] 3.89477e-06
FGA [NCBI] 3.71597e-06
POMC [NCBI] 3.65733e-06
BCR [NCBI] 3.59127e-06
RNASE3 [NCBI] 3.54934e-06
AKR1B1 [NCBI] 3.47904e-06
IDUA [NCBI] 3.438e-06
BSG [NCBI] 3.33324e-06
SHBG [NCBI] 3.03975e-06
panencephalitis, subacute sclerosing [NCBI] 2.9443e-06
CCK [NCBI] 2.92892e-06
MEN1 [NCBI] 2.77124e-06
PAEP [NCBI] 2.52718e-06
GTS [NCBI] 2.44572e-06
PCI [NCBI] 2.09927e-06
porphyria variegata [NCBI] 2.04479e-06
gaucher disease, type i [NCBI] 2.04479e-06
CHH [NCBI] 2.04479e-06
APC [NCBI] 1.87976e-06
UCN [NCBI] 1.85199e-06
LPI [NCBI] 1.80325e-06
TG [NCBI] 1.6553e-06
AVP [NCBI] 1.65487e-06
SOD2 [NCBI] 1.64686e-06
von willebrand disease [NCBI] 1.63057e-06
IGFALS [NCBI] 1.60455e-06
TNC [NCBI] 1.4319e-06
VDR [NCBI] 1.32058e-06
ALB [NCBI] 1.28701e-06
SMAX1 [NCBI] 1.17375e-06
G6PD [NCBI] 1.06551e-06
GHRH [NCBI] 9.25617e-07
EIG [NCBI] 9.10299e-07
PLTP [NCBI] 8.8208e-07
SMA1 [NCBI] 8.00652e-07
FMF [NCBI] 7.74309e-07
MBP [NCBI] 7.50266e-07
apnea, obstructive sleep [NCBI] 7.38842e-07
ACE [NCBI] 7.21413e-07
ABCG2 [NCBI] 7.02596e-07
CGD [NCBI] 5.52257e-07
TNFRSF11B [NCBI] 4.96418e-07
PEDF [NCBI] 4.52072e-07
MJD [NCBI] 4.51854e-07
PCD [NCBI] 3.9734e-07
SLC6A3 [NCBI] 3.66305e-07
DMD [NCBI] 3.53512e-07
CNTF [NCBI] 3.17428e-07
KCNH2 [NCBI] 2.40112e-07
JAK2 [NCBI] 2.40112e-07
PD [NCBI] 2.38393e-07
ALD [NCBI] 2.27503e-07
PLG [NCBI] 1.77225e-07
GIP [NCBI] 1.44949e-07
TNFSF6 [NCBI] 1.20392e-07
EV [NCBI] 9.89903e-08
CFTR [NCBI] 5.56305e-08
IL2 [NCBI] 4.95104e-08
GDNF [NCBI] 4.05863e-08
INS [NCBI] 3.61295e-08
SLC6A4 [NCBI] 3.61295e-08
PYY [NCBI] 3.54067e-08
MBL2 [NCBI] 3.41279e-08
HD [NCBI] 2.02585e-08
hla-d histocompatibility type [NCBI] 1.16435e-08
ADHD [NCBI] 2.96591e-09
NR1I2 [NCBI] 1.93477e-09



Database Center for Life Science